In patients with acquired lipodystrophy due to highly active anti-retroviral therapy for HIV infection, there was no reverse increase in GH levels during 2-hour OGTT, which suggests the effect of redistribution of subcutaneous adipose tissue on a longer suppression of GH [75]. Here, GH1 is linked to acquired lipodystrophy.